1. Home
  2. QUIK vs FHTX Comparison

QUIK vs FHTX Comparison

Compare QUIK & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuickLogic Corporation

QUIK

QuickLogic Corporation

SELL

Current Price

$9.36

Market Cap

196.7M

Sector

Technology

ML Signal

SELL

Logo Foghorn Therapeutics Inc.

FHTX

Foghorn Therapeutics Inc.

HOLD

Current Price

$1.89

Market Cap

173.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QUIK
FHTX
Founded
1988
2015
Country
United States
United States
Employees
51
N/A
Industry
Semiconductors
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
196.7M
173.4M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
QUIK
FHTX
Price
$9.36
$1.89
Analyst Decision
Buy
Buy
Analyst Count
4
10
Target Price
★ $23.00
$4.17
AVG Volume (30 Days)
184.2K
★ 1.2M
Earning Date
11-10-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 25.32
EPS
N/A
★ N/A
Revenue
$20,112,000.00
★ $30,909,000.00
Revenue This Year
$73.33
N/A
Revenue Next Year
$16.92
$15.98
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 36.75
52 Week Low
$5.28
$1.79
52 Week High
$24.33
$7.61

Technical Indicators

Market Signals
Indicator
QUIK
FHTX
Relative Strength Index (RSI) 28.31 16.46
Support Level $8.72 $1.79
Resistance Level $10.14 $5.35
Average True Range (ATR) 0.45 0.25
MACD -0.16 -0.01
Stochastic Oscillator 13.75 4.66

Price Performance

Historical Comparison
QUIK
FHTX

About QUIK QuickLogic Corporation

QuickLogic Corp is a fabless semiconductor company developing programmable logic semiconductor technologies, including embedded Field Programmable Gate Array (eFPGA) intellectual property (IP) and specialized FPGA devices. Its product offerings include the eFPGA IP licensing business and associated professional services, as well as a range of FPGA silicon products, including EOS, ArcticLink III, PolarPro 3, PolarPro II, PolarPro, and Eclipse II products, among others. The company's customers come from various markets, including aerospace and defense, industrial and infrastructure systems, data processing and computing platforms, and certain embedded and edge computing applications. Geographically, it generates maximum revenue from North America and the rest from Asia Pacific and Europe.

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.

Share on Social Networks: